180 related articles for article (PubMed ID: 34406079)
1. A
Zgheib NK; El-Khoury H; Maamari D; Basbous M; Saab R; Muwakkit SA
Per Med; 2021 Sep; 18(5):431-439. PubMed ID: 34406079
[TBL] [Abstract][Full Text] [Related]
2. Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia.
Karol SE; Yang W; Van Driest SL; Chang TY; Kaste S; Bowton E; Basford M; Bastarache L; Roden DM; Denny JC; Larsen E; Winick N; Carroll WL; Cheng C; Pei D; Fernandez CA; Liu C; Smith C; Loh ML; Raetz EA; Hunger SP; Scheet P; Jeha S; Pui CH; Evans WE; Devidas M; Mattano LA; Relling MV
Blood; 2015 Oct; 126(15):1770-6. PubMed ID: 26265699
[TBL] [Abstract][Full Text] [Related]
3. ALL and osteonecrosis.
Gaynon PS
Blood; 2015 Oct; 126(15):1734-5. PubMed ID: 26450951
[TBL] [Abstract][Full Text] [Related]
4. A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemia.
Finkelstein Y; Blonquist TM; Vijayanathan V; Stevenson KE; Neuberg DS; Silverman LB; Vrooman LM; Sallan SE; Cole PD
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27957785
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.
Kawedia JD; Kaste SC; Pei D; Panetta JC; Cai X; Cheng C; Neale G; Howard SC; Evans WE; Pui CH; Relling MV
Blood; 2011 Feb; 117(8):2340-7; quiz 2556. PubMed ID: 21148812
[TBL] [Abstract][Full Text] [Related]
6. Influence of BCL2L11 polymorphism on osteonecrosis during treatment of childhood acute lymphoblastic leukemia.
Plesa M; Gagné V; Glisovic S; Younan M; Sharif-Askari B; Laverdière C; Alos N; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
Pharmacogenomics J; 2019 Feb; 19(1):33-41. PubMed ID: 29282361
[TBL] [Abstract][Full Text] [Related]
7. Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patients.
Gagné V; Aubry-Morin A; Plesa M; Abaji R; Petrykey K; St-Onge P; Beaulieu P; Laverdière C; Alos N; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
Pharmacogenomics; 2019 Nov; 20(17):1189-1197. PubMed ID: 31686588
[No Abstract] [Full Text] [Related]
8. Bone pain at leukemia diagnosis and other risk factors for symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
Barzilai-Birenboim S; Yacobovich J; Zalcberg Y; Arad-Cohen N; Avrahami G; Gilad G; Litichever N; Izraeli S; Elitzur S
Pediatr Blood Cancer; 2021 Aug; 68(8):e29033. PubMed ID: 33788395
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the Relationship Between
Erdem M; Tüfekçi Ö; Kızıldağ S; Yılmaz Ş; Kızmazoğlu D; Eroğlu Filibeli B; Ören H
Turk J Haematol; 2019 Feb; 36(1):12-18. PubMed ID: 30251958
[TBL] [Abstract][Full Text] [Related]
10. Bloodstream infections exacerbate incidence and severity of symptomatic glucocorticoid-induced osteonecrosis.
Finch ER; Janke LJ; Smith CA; Karol SE; Pei D; Cheng C; Kaste SC; Inaba H; Pui CH; Wolf J; Relling MV
Pediatr Blood Cancer; 2019 Jun; 66(6):e27669. PubMed ID: 30758124
[TBL] [Abstract][Full Text] [Related]
11. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.
Mattano LA; Devidas M; Nachman JB; Sather HN; Hunger SP; Steinherz PG; Gaynon PS; Seibel NL;
Lancet Oncol; 2012 Sep; 13(9):906-15. PubMed ID: 22901620
[TBL] [Abstract][Full Text] [Related]
12. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
den Hoed MA; Pluijm SM; te Winkel ML; de Groot-Kruseman HA; Fiocco M; Hoogerbrugge P; Leeuw JA; Bruin MC; van der Sluis IM; Bresters D; Lequin MH; Roos JC; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2015 Dec; 100(12):1564-70. PubMed ID: 26405155
[TBL] [Abstract][Full Text] [Related]
13. British OsteoNEcrosis Study (BONES) protocol: a prospective cohort study to examine the natural history of osteonecrosis in older children, teenagers and young adults with acute lymphoblastic leukaemia and lymphoblastic lymphoma.
Amin N; Kinsey S; Feltbower R; Kraft J; Whitehead E; Velangi M; James B
BMJ Open; 2019 May; 9(5):e027204. PubMed ID: 31122988
[TBL] [Abstract][Full Text] [Related]
14. Genetics of pleiotropic effects of dexamethasone.
Ramsey LB; Pounds S; Cheng C; Cao X; Yang W; Smith C; Karol SE; Liu C; Panetta JC; Inaba H; Rubnitz JE; Metzger ML; Ribeiro RC; Sandlund JT; Jeha S; Pui CH; Evans WE; Relling MV
Pharmacogenet Genomics; 2017 Aug; 27(8):294-302. PubMed ID: 28628558
[TBL] [Abstract][Full Text] [Related]
15. A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
French D; Hamilton LH; Mattano LA; Sather HN; Devidas M; Nachman JB; Relling MV;
Blood; 2008 May; 111(9):4496-9. PubMed ID: 18285546
[TBL] [Abstract][Full Text] [Related]
16. Genetic Biomarkers to Identify the Risk of Osteonecrosis in Children with Acute Lymphoblastic Leukemia.
den Hoed MA; Pluijm SM; Uitterlinden AG; Pieters R; van den Heuvel-Eibrink MM
Mol Diagn Ther; 2016 Dec; 20(6):519-522. PubMed ID: 27365083
[TBL] [Abstract][Full Text] [Related]
17. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
Mattano LA; Sather HN; Trigg ME; Nachman JB
J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
[TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis in children treated for acute lymphoblastic leukemia: a magnetic resonance imaging study after treatment.
Ojala AE; Lanning FP; Pääkkö E; Lanning BM
Med Pediatr Oncol; 1997 Oct; 29(4):260-5. PubMed ID: 9251731
[TBL] [Abstract][Full Text] [Related]
19. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
Levien MG
Clin Pediatr (Phila); 2002; 41(1):63-4. PubMed ID: 11866371
[No Abstract] [Full Text] [Related]
20. Association Between NR3C1 Gene Polymorphisms and Toxicity Induced by Glucocorticoids Therapy in Saudi Children with Acute Lymphoblastic Leukemia.
El-Fayoumi R; Hagras M; Abozenadaha A; Bawazir W; Shinawi T
Asian Pac J Cancer Prev; 2018 May; 19(5):1415-1423. PubMed ID: 29802709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
